Monitoring of the neonate undergoing MR imaging: technical considerations. Work in progress

Instrument monitoring of vital signs in neonates undergoing magnetic resonance (MR) imaging can be difficult because of the unique environmental restrictions imposed by the imager. The authors present their experience with monitoring more than 50 newborn infants and discuss the interaction of monitoring devices with the MR imager. Several MR-compatible monitors allow continuous evaluation of body temperature, heart rate, blood pressure, and auscultation of heart sounds and respiration in mechanically ventilated infants. Signal-to-noise (S/N) ratio measurements taken during imaging of the head of an infant with these monitors in place did not differ appreciably from the ratio obtained during imaging without monitors. Tip angles should be optimized to account for widely varying head size among neonates, since adverse monitoring effects are significantly compounded by improper tip angle adjustment.     

Lipomatous tumors and tumors with fatty component: MR imaging potential and comparison of MR and CT results

This retrospective study was performed to assess the potential of magnetic resonance (MR) imaging for demonstrating various types of lipomatous tumors and tumors with fatty component and to compare the results of MR with those of computed tomography (CT). MR examinations of 17 patients with 18 lipomatous tumors (16, benign; two, liposarcoma) and two patients with fibrosarcomas were reviewed; CT scans were available for comparison in all patients. In the 16 benign lesions (12 benign lipomas, two ovarian dermoid cysts, and two renal angiomyolipomas), the fatty component of the tumors was readily demonstrated by both MR and CT. The T1 and T2 relaxation times and spin density of benign lipomatous tumors were in a range similar to those of normal subcutaneous fat. Differentiation between lipomas and liposarcomas was achieved with both MR and CT. On MR images using a short repetition time (TR = .5 sec), liposarcomas (long T1) were imaged with a lower MR intensity than lipomas (short T1).     

Obstetrical magnetic resonance imaging: fetal anatomy

Nine patients who were 34-36 weeks pregnant underwent magnetic resonance (MR) imaging. Sagittal images using spin echo technique (TR 2.0 sec, TE 28 msec) were optimal for delineating fetal anatomy. The fetal cardiovascular, pulmonary, and central nervous systems were depicted in all cases. The heart and major vessels were readily seen due to the natural contrast of flowing blood. The intensity of the fluid-filled lungs greatly increased with a longer TR or TE, delimiting thorax from liver. The brain was relatively featureless due to the lack of gray-white matter differentiation. The umbilical cord within the amniotic fluid and its insertion into the placenta and fetus was identified in all cases. MR is a new modality for fetal imaging that offers tissue-characterization information that complements the superior anatomic detail of ultrasound scanning.     

Percutaneous transluminal renal angioplasty: initial and long-term results

Renal artery stenosis in 201 patients with hypertension was treated with percutaneous transluminal renal angioplasty (PTRA). A total of 213 procedures were performed as treatment of 262 separate stenosis. The stenosis was caused by atherosclerosis in 134 cases and by fibromuscular dysplasia (FMD) in 52 cases; the cause was indeterminate in 27 cases. Of the 213 procedures, 172 were successful or resulted in improvement, for a technical success rate of 80.8%. The initial clinical results could be evaluated in 210 cases; cure or improvement was achieved in 80%. There were 23 cases in which neither technical nor clinical success was achieved. Data on the remaining 187 cases were the basis of this long-term follow-up study. The cumulative patency rate at 5 years was 80% in the atherosclerosis group, 89% in the FMD group, and 74% in the indeterminate group. The mortality was less than 1%. Because spasm occurred in 33 cases, causing an infarction in ten instances, antispasmodic medication seems warranted. These long-term results indicate that PTRA is the treatment of choice in patients with renovascular hypertension.